Acute and acute severe (fulminant) autoimmune hepatitis.
about
Brazilian society of hepatology recommendations for the diagnosis and management of autoimmune diseases of the liverRole of liver progenitors in acute liver injuryReview article: the management of autoimmune hepatitis beyond consensus guidelinesDiagnosis and Management of Autoimmune Hepatitis: Current Status and Future DirectionsCausality assessment for suspected DILI during clinical phases of drug developmentAnti-mitochondrial M2 antibody-positive autoimmune hepatitisChallenges in the diagnosis and management of autoimmune hepatitis.Autoimmune hepatitis in diverse ethnic populations and geographical regions.Transitioning from Idiopathic to Explainable Autoimmune Hepatitis.Targeting Hepatic Fibrosis in Autoimmune Hepatitis.Challenges and difficulties in pathological diagnosis of autoimmune hepatitis.Global Disparities and Their Implications in the Occurrence and Outcome of Autoimmune Hepatitis.Low-grade elevation of fibrinogen-degradation products is an important parameter to identify acute presentation of autoimmune hepatitis.A real-world study focused on the long-term efficacy of mycophenolate mofetil as first-line treatment of autoimmune hepatitis.Infectious complications, steroid use and timing for emergency liver transplantation in acute liver failure: analysis in a Japanese center.Prevalence and Significance of Autoantibodies in Children With Acute Liver Failure.A case of primary biliary cirrhosis and autoimmune hepatitis overlap showing acute presentation and transient seropositivity for immunoglobulin G and anti-nuclear antibody.Analysis of infectious complications and timing for emergency liver transplantation in autoimmune acute liver failure.Clinical features of pediatric autoimmune hepatitis in Japan: A nationwide survey.Immunoserological and histological differences between autoimmune hepatitis with acute presentation and chronic autoimmune hepatitis.Results of a fast-track referral system for urgent outpatient hepatology visits.Clinical and Pathological Characteristics of Autoimmune Hepatitis with Acute Presentation.A Tale of Unequal Substitution: Minocycline and Acute Autoimmune Hepatitis.
P2860
Q26766699-50EBA564-1A3F-4E5A-92ED-4EFDBB59AB82Q26823720-6741E7D1-8789-492A-A73E-91DF1C3D17FCQ26864272-7BD9E977-8326-40F6-83A9-97A571EE7914Q28076505-AF5FE8CD-E410-4841-A427-30F09A03B2DCQ34417032-B112532C-26BC-4BE9-AA46-CD6B35D298F1Q36081422-D2213AB6-E0D8-47DA-97C2-CF378F2DBEF7Q37640582-E71C1038-DC60-490F-AED3-035A368E2AF4Q38103631-65B0D8FE-E6B8-4CFD-A54D-4C382ED78F47Q38496935-A68C540E-496F-46E2-BBA7-C42588CE8D21Q38902371-49C0516B-47F5-4AA8-8883-214983EC4C30Q39413444-FABBA7D0-9A63-4E2B-85DC-7A7224A94F16Q39436336-A592488D-2B06-4922-A610-9CCDC1D68D35Q39780824-96733BD7-BDA3-44F0-89E4-4FCE84ACED02Q39909124-F0407D2E-9144-4655-BDC5-679D4C4EC609Q40540107-78DCCA33-05F3-46AD-8ECD-6760E1F98D00Q40633201-D5E8A04E-7A69-408D-972D-3B7F611DAD67Q40728797-36E55948-E560-481F-8CE4-A232581F6661Q40819149-E4758617-97C2-49E3-ABFA-0CE2CFA3202AQ47586594-B58CE6E7-DA74-4D77-A333-0D4619EA6556Q50882365-86EC1D0F-3126-45BE-9EB2-29E362F960C0Q51003730-71147559-AC2F-446D-9F4D-E1FD38EE988BQ54962561-043A519B-B6D3-4922-9D29-FE26699276E9Q55314396-392E01C5-0ABF-45EC-A6AB-9A5ADE5234A7
P2860
Acute and acute severe (fulminant) autoimmune hepatitis.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Acute and acute severe (fulminant) autoimmune hepatitis.
@en
type
label
Acute and acute severe (fulminant) autoimmune hepatitis.
@en
prefLabel
Acute and acute severe (fulminant) autoimmune hepatitis.
@en
P2860
P1476
Acute and acute severe (fulminant) autoimmune hepatitis.
@en
P2093
Albert J Czaja
P2860
P2888
P304
P356
10.1007/S10620-012-2445-4
P577
2012-10-23T00:00:00Z
P6179
1021147835